Evidence mapPaperPMID 41233045Full record

ReviewThe lancet. Diabetes & endocrinology2025

Life stage transitions for people with type 1 diabetes.

Rebecca J Vitale, Elena Toschi, Jacob Ortega, Medha N Munshi, Ruth S Weinstock, Lori M Laffel, Anna R Kahkoska

Abstract readReview
In one paragraph

Review in The lancet. Diabetes & endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rebecca J VitaleDivision of Pediatric Endocrinology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Division of Endocrinology and Metabolism, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: rebecca_vitale@med.unc.edu.
Elena ToschiJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Jacob OrtegaCampbell University School of Osteopathic Medicine, Leon Levine Hall of Medical Sciences, Lillington, NC, USA.
Medha N MunshiJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Ruth S WeinstockDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, State University of New York Upstate Medical University, Syracuse, NY, USA.
Lori M LaffelJoslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Anna R KahkoskaDivision of Endocrinology and Metabolism, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Nutrition, Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Funding

Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)K12DK133995 · STANFORD UNIVERSITY · 2025 to 2025
$3.7M
Building a Real-World Evidence Base for Continuous Glucose Monitoring in Older Adults with DiabetesK01AG084971 · UNIV OF NORTH CAROLINA CHAPEL HILL · 2025 to 2025
$127k
NIA NIH HHS K01 AG084971NIDDK NIH HHS K12 DK133995
6 · The paper itself

Abstract

Type 1 diabetes affects individuals of all ages, with different clinical priorities and support needs at different stages of life. In this Personal View, we define the two major transitions that occur across the lifespan in type 1 diabetes: the emerging adult transition (typically occurring between age 18 years and age 25 years, as individuals transition to self-management and transfer to adult care), and the older adult transition (occurring at variable ages as individuals develop comorbidities and complications that could require increased assistance with management and customisation of glycaemic targets). We identify a framework considering these life stage transitions, including eight domains common to both stages. These domains include the following: needs from the medical care team, diabetes self-management education and support needs, adapting diabetes management to evolving physiology, comorbidities affecting self-care and diabetes management, changing neurocognitive physiology and self-management capabilities, functional status and activity levels, degrees of independence (living situations and social support), and changing financial context. We discuss key clinical gaps and research needs, focusing on how the similarities in these major transitions can be leveraged to improve care for people with type 1 diabetes across the lifespan.

Indexed as

Diabetes Mellitus, Type 1Self-ManagementTransition to Adult CareAdolescentAdultHumansSelf CareSocial SupportYoung Adult

Identifiers

PMID41233045
PMCPMC12768306

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.